Luciana Basili Dias Candidíase vulvovaginal em pacientes gestantes

Referências Bibliográficas 90
for Antifungal Susceptibility Testing of Candida Species. Antimicrob. Agents Chemother. 2002;
46: 3644-7.
Cuenca-Estrela M, Rodriguez-Tudella JL. Pueden basarse lãs indicationes de los antifúngicos em
los estudios de sensibilidad? Rev Iberoam Micol. 2002; 19: 133-8.
Czaika V, Tietz HJ, Schmabreck A, Sterry W, Schultze W. Antifungal susceptibility testing in
chronically recurrent vaginal candidosis as basis for effective therapy. Mycoses. 2000; 43: 45-50.
Espinel-Ingroff A, Barchiesi F, Hanzen KC, Martinez-Suares JV, Scalise G. Standardization of
antifungal susceptibility testing and clinical relevance. Med. Mycol.1998; 36: 68-78.
Espinel-Ingroff A, Kerkering TM, Fromtling RA, Bartizal K, Galgiani JN, Villareal K, et al. A
collaborative of broth macrodiluition and microdilution antifungal susceptibility tests. J. Clin.
Microbiol. 1992; 30: 3138-45.
Espinel-Ingroff A, Pfaller MA. Antifungal agents and susceptibility testing. In: Murray PR,
Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology.
Washington: ASM PRESS; 1995. p.1405-14.
Ferracin I, Oliveira RMW. Corrimento Vaginal: Causa, Diagnóstico e Tratamento
Farmacológico. Infarma. 2005; 17: 82-6.
Ferrari TCA, Hamdan JS. Drogas antifúngicas. In: Rocha MOC, Pedroso ERP, Fonseca JGM,
Silva AO, editores. Terapêutica Clínica. Rio de Janeiro: Guanabara Koogan; 1998. p. 251-66.
Ferrazza MHSH, Maluf MLF, Lopes Consolaro ME, Shinobu CS, Svidzinski TIE, Batista MR.
Caracterização de leveduras isoladas da vagina e sua associação com candidíase vulvovaginal
em duas cidades do sul do Brasil. Rev. Bras. Ginecol. Obstet. 2005; 27: 58-63.
Ferrer J. Vaginal candidosis: epidemiological and etiological factors. Int. J. Gynecol. Obstet.
2000; 71: 21-7.